Adverse events related to medications identified by a canadian poison centre

Canadian Journal of Clinical Pharmacology

Volumn 18, Issue 2, 2011, Pages

  Ackroyd Stolarz, S A ^a   Mackinnon, N J ^a   Murphy, N ^a   Gillespie, E ^b   Zed, P J ^c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b IWK HEALTH CENTRE   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adverse drug reaction reporting systems; Drug toxicity; Medication errors; Poison control centers

Indexed keywords

ADVERSE DRUG REACTION; ARTICLE; CHILD; DATA ANALYSIS; DATA BASE; ELECTRONIC MEDICAL RECORD; FEASIBILITY STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; POISON CENTER; RETROSPECTIVE STUDY; SCHOOL CHILD; THERAPEUTIC ERROR; ADOLESCENT; ADULT; CANADA; CROSS-SECTIONAL STUDY; DRUG SURVEILLANCE PROGRAM; FACTUAL DATABASE; HOSPITALIZATION; MEDICATION ERROR; PILOT STUDY; PRESCHOOL CHILD; STATISTICS;

DRUG;

ADOLESCENT; ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; HOSPITALIZATION; HUMANS; MALE; MEDICATION ERRORS; NOVA SCOTIA; PHARMACEUTICAL PREPARATIONS; PILOT PROJECTS; POISON CONTROL CENTERS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79959826677     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997;277:307-11.
2. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001;41:192-9.
3. Kidney T, MacKinnon NJ. Preventable drugrelated morbidity and mortality in older adults: a Canadian cost-of-illness model. Geriatrics Today 2001;4:120.
4. Thomsen LA, Winterstein AG, Sondergaard B, Haugbolle LS, Melander A. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007;41(9):1411-26.
5. Elixhauser A, Owens P (AHRQ). Adverse drug events in US hospitals, 2004. Healthcare Cost and Utilization Project Statistical Brief #29, April 2007. Rockville (MD): Agency for Healthcare Research and Quality; 2007. Retrieved June 4, 2010. http://www.hcupus.ahrq.gov/reports/statbriefs/sb29.pdf
6. Budnitz DS, Pollock DA, Weidenback KN, Mendelsohn AB, Schroeder TJ, Annest JL. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006;296:1858-66.
7. Health Canada. MedEffect TM Canada. The Health Canada site; 2009. Retrieved June 4, 2010. http://www.hc-sc.gc.ca/dhpmps/ medeff/index-eng.php
8. Carleton BC, Smith MA, Gelin MN, Heathcote SC. Pediatric adverse drug reaction reporting: understanding and future directions. Can J Clin Pharmacol 2007;14(1):e45-e57.
9. Shah K, Barker KA. Out-of-hospital medication errors: A 6-year analysis of the national poison data system. Pharmacoepidem Drug Saf 2009;18:1080-5.
10. Chyka PA. Role of US poison centers in adverse drug reaction monitoring. Vet Human Toxicol 1999;41(6):400-2.
11. Chyka PA, McCommon SW. Reporting of adverse drug reactions by poison control centers in the US. Drug Saf 2000;23(1):87-93.
12. Cobaugh DJ, Krenzelok EP. Adverse drug reactions and therapeutic errors in older adults: a hazard factor analysis of poison center data. Am J Health-Syst Pharm 2006;63:2228-34.
13. Volans GN, Karalliedde L, Wiseman HM. Poison centres and the reporting of adverse drug events: the case for further development. Drug Saf 2007;30(3):191-4.
14. Vassilev ZP, Chu AF, Ruck B, Adams EH, Marcus SM. Evaluation of adverse drug reactions reported to a poison control center between 2000 and 2007. Am J Health-Syst Pharm 2009;66:481-7.
15. Watson WA, Litovitz TL, Belson MG, et al. The Toxic Exposure Surveillance System (TESS)©: Risk assessment and real-time toxicovigilance across United States poison centers. Toxicol Appl Pharmacol 2005;207:S604-10.
16. Spiller HA, Griffith JRK, Anderson DL, Weber JA. Poison centers detect an unexpectedly frequent number of adverse drug reactions to lisdexamfetamine. Ann Pharmacother 2008;42:1142-3.
17. Canadian Association of Poison Control Centres (CAPCC). Provincial Centres. The Canadian Association of Poison Control Centres site; 2008. Retrieved June 4, 2010. http://www.capcc.ca/provcentres/centres.html
18. Statistics Canada. Population by year, by province and territory. Statistics Canada site; 2010. Retrieved June 4, 2010. http://www40.statcan.gc.ca/l01/cst01/demo02a-eng.htm
19. Neuman T. Instructions for the American Association of Poison Centers Toxic Exposure Surveillance System (TESS)©. Aurora (CO): American Association of Poison Centers, 2001.
20. Hazell L, Shakir SAW. Under-reporting of adverse drug reactions: a systematic review. Drug Saf 2006;29(5):385-96.
21. Osborne C. Information management for busy practitioners: Adverse drug reactions: Investigating to Reporting. J Can Acad Child Adolesc Psychiatry 2010;19:46-7.
22. Canadian Institute for Health Information. Canadian Medication Incident Reporting and Prevention System (CMIRPS). The Canadian Institute for Health Information site; 2008. Retrieved June 4, 2010. http://secure.cihi.ca/cihiweb/en/downloads/CMIRPS_Charter_Exec_Summary_FINAL_e.pdf
23. Holbrook A, Keshavjee K, Sebaldt R, et al. Evaluation of data sources to support pharmcosurveillance. Hamilton (ON): Health Canada; 2004. Retrieved June 4, 2010. http://individual.utoronto.ca/grootendorst/pdf/Evaluation_of_data_sources_to_support.pdf